Three pregnancies in women with long-term azathioprine treatment for inflammatory bowel disease

被引：0
|
作者：
Bourgaux, JF
Bondu, F
Raffanel, C
Balmes, JL
机构：
来源：
PRESSE MEDICALE | 1996年 / 25卷 / 30期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1389 / 1390
页数：2
相关论文
共 50 条
  • [11] Predictors of short and long term response to azathioprine in patients with inflammatory bowel disease
    Mardini, H
    Selby, L
    Arsenescu, R
    Winter, T
    de Villiers, WJ
    GASTROENTEROLOGY, 2005, 128 (04) : A582 - A582
  • [12] Long-term safety and effectiveness of azathioprine in the management of inflammatory bowel disease: A real-world experience
    Yewale, Rohan, V
    Ramakrishna, Balakrishnan S.
    Doraisamy, Babu Vinish
    Basumani, Pandurangan
    Venkataraman, Jayanthi
    Jayaraman, Kayalvizhi
    Murali, Ananthavadivelu
    Premkumar, Karunakaran
    Kumar, Akkim Sathish
    JGH OPEN, 2023, 7 (09): : 599 - 609
  • [13] TPMT in the treatment of inflammatory bowel disease with azathioprine
    Qasim, A
    Seery, J
    Buckley, M
    Morain, CO
    GUT, 2003, 52 (05) : 767 - 767
  • [14] Long-term treatment with infliximab in inflammatory bowel disease: safety and tolerability issues
    Caviglia, Renato
    Boskoski, Ivo
    Cicala, Michele
    EXPERT OPINION ON DRUG SAFETY, 2008, 7 (05) : 617 - 632
  • [15] Vedolizumab Immunogenicity With Long-Term or Interrupted Treatment of Patients With Inflammatory Bowel Disease
    Wyant, Timothy
    Yang, Lili
    Lirio, Richard A.
    Rosario, Maria
    JOURNAL OF CLINICAL PHARMACOLOGY, 2021, 61 (09): : 1174 - 1181
  • [16] Long-term treatment of inflammatory bowel disease associated spondyloarthropathy with infliximab.
    Antivalle, Marco
    Mutti, Alessandra
    Bertani, Luca
    Randisi, Giovanna
    Vulpio, Laura
    Ardizzone, Sandro
    Colombo, Elisabetta
    Carrabba, Mario
    ARTHRITIS AND RHEUMATISM, 2006, 54 (09): : S472 - S472
  • [17] Hepatic effects of long-term methotrexate use in the treatment of inflammatory bowel disease
    Te, HS
    Schiano, TD
    Kuan, SF
    Hanauer, SB
    Conjeevaram, HS
    Baker, AL
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2000, 95 (11): : 3150 - 3156
  • [18] Long-term safety of 5 aminosalicylates (Mesalamine) in the treatment of inflammatory bowel disease
    Trivedi, Chirag D.
    Mithani, Sima
    Chichili, Eiswarya
    Xing, Danli
    Das, Kiron M.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2007, 102 : S483 - S484
  • [19] Inflammatory bowel disease: long-term therapeutic challenges
    Ashton, James J.
    Green, Zachary
    Kolimarala, Vinod
    Beattie, R. Mark
    EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2019, 13 (11) : 1049 - 1063
  • [20] Long-term safety of vedolizumab for inflammatory bowel disease
    Loftus, Edward V., Jr.
    Feagan, Brian G.
    Panaccione, Remo
    Colombel, Jean-Frederic
    Sandborn, William J.
    Sands, Bruce E.
    Danese, Silvio
    D'Haens, Geert
    Rubin, David T.
    Shafran, Ira
    Parfionovas, Andrejus
    Rogers, Raquel
    Lirio, Richard A.
    Vermeire, Severine
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2020, 52 (08) : 1353 - 1365
12345